This is Joe's response to the variant issue: "W
Post# of 36537
(Total Views: 535)
Posted On: 12/19/2020 1:48:22 PM
This is Joe's response to the variant issue:
"We don’t use the full spike protein, this will be not so good for the Gene Therapies because in the spike protein their are about 165 epitopes which all are used a new strain will have variations of the 165, we on the other hand will have no problem because we use only the epitopes that are neutralizing, no th2 or isle 5,6,8, our epitopes are the foundation epitopes of the virus envelope, me brain and core, so the chances of one of those epitopes changing is slim to non, just like COVID SARS the main epitopes are a match to Covid 19, our vaccine from Sars Covid and today’s Covid would be effective for both strains."
"We don’t use the full spike protein, this will be not so good for the Gene Therapies because in the spike protein their are about 165 epitopes which all are used a new strain will have variations of the 165, we on the other hand will have no problem because we use only the epitopes that are neutralizing, no th2 or isle 5,6,8, our epitopes are the foundation epitopes of the virus envelope, me brain and core, so the chances of one of those epitopes changing is slim to non, just like COVID SARS the main epitopes are a match to Covid 19, our vaccine from Sars Covid and today’s Covid would be effective for both strains."
(4)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼